News

Hugel Inc., a leading global medical aesthetics company, said on Monday it had hosted H.E.L.F. Training: BlueRose x Botulax, a seminar on suturing and botulinum toxin treatment, for South Korean medical practitioners on September 26.

​

The seminar comprised lectures and live demonstrations on the procedure for polydioxanone (PDO) and polycaprolactone (PCL) sutures and botulinum toxin for the same day. Some 20 medical experts learned the knowledge and techniques for safe and effective use of the threads and toxins at the academic event.

​

Dr. Jung Jae-yoon, medical director at Mielle Clinic in Cheongdam, led the lecture on same-day procedures for absorbable sutures and botulinum toxins and explained the standards for selecting toxin products.

​

He also performed live demonstrations on treatment with Hugel's suture BlueRose, globally known as Licellvi, and botulinum toxin Botulax for sagging skin around the eyes and on the midface.

​

“We are glad to have successfully completed the training seminar with Dr. Jung. Hugel will continue to provide academic programs to meet needs in the medical aesthetic field,” a Hugel official said.

​

The company has hosted the academic forum H.E.L.F., or Hugel Expert Leader’s Forum, every year since 2013 to share advanced knowledge and skills with Korean and overseas medical aesthetic industry leaders.

​

About Hugel

​

Established in 2001, Hugel is a leading global medical aesthetics company that manufactures injectables for skin rejuvenation such as botulinum toxin, hyaluronic acid fillers and skin boosters as well as absorbable sutures and cosmetics products. The company is the only South Korean supplier to the world’s three largest botulinum toxin markets, the US, China and Europe. It exports medical aesthetic products and devices to around 70 countries and operates eight global subsidiaries in the US, Australia, Canada, Taiwan, China, Hong Kong and Singapore.